p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference53 articles.
1. Effects of Concomitant Cisplatin and Radiotherapy on Inoperable Non-Small-Cell Lung Cancer
2. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer.
3. Daily low-dose cisplatin plus concurrent high-dose thoracic irradiation in locally advanced unresectable non-small-cell lung cancer: results of a phase II Southwest Oncology Group study.
4. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III non-small cell lung cancer
5. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: a Hoosier Oncology Group protocol.
Cited by 63 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Taxanes as radiosensitizers;Anti-Cancer Drugs;2014-06
2. Mutant p53 and the Response to Chemotherapy and Radiation;Subcellular Biochemistry;2014
3. p53-associated differential response to platinum-gemcitabine and platinum-paclitaxel in advanced non-small cell lung cancer;ASIAN BIOMED;2013
4. Weekly paclitaxel, gemcitabine, and external irradiation followed by randomized farnesyl transferase inhibitor R115777 for locally advanced pancreatic cancer;OncoTargets and Therapy;2012-08
5. Tumor and host factors that may limit efficacy of chemotherapy in non-small cell and small cell lung cancer;Critical Reviews in Oncology/Hematology;2010-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3